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INTRODUCTION
▪COVID-19 is a disease caused by a novel Coronavirus (SARS-CoV-2) 
originating in Wuhan, China around December 2019. On March 11, 2020 it 
was declared a pandemic by the World Health Organization (WHO) as the 
number of infections rapidly grew around the world. Currently, cases have 
described COVID-19 involvement in respiratory, gastrointestinal, 
neurological, and ocular tissues. Respiratory droplets and direct contact are 
the most probable transmission routes, although aerosolized sneezes and 
coughs may also contaminate the immediate surroundings.[1] 
▪COVID-19 most commonly causes respiratory symptoms such as dyspnea 
and cough which may progress to pneumonia and ARDS in a subset of 
patients, however recent studies have demonstrated neurological 
manifestations such as dizziness, headache, hypogeusia, hyposmia, 
neuralgia, impaired consciousness, acute CVD, ataxia, and seizure.[2][3] 
SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2) receptor 
in human cells which is hypothesized to allow CNS access by ACE2 receptor 
expressing glial cells, neurons, endothelial and arterial smooth muscle cells 
in the brain.[4] A recent case of meningitis/encephalitis with SARS-CoV-2 
RNA detected in the CSF directly supports the neuroinvasive ability of the 
virus.[5] In addition, SARS-CoV-2 has a similar viral structure and receptor-
binding domain to SARS-CoV, a more well studied virus that demonstrated 
olfactory bulb infection with transneuronal spread in mice leading to 
neuronal loss.[4] Considering these characteristics, it is reasonable to 
conclude that SARS-CoV-2 shows neurotropism that can manifest 
neurological symptoms in an infected individual.
▪Recently, there have been case reports of neuro-ophthalmological 
manifestations in association with COVID-19 such as diplopia, Miller-Fisher 
syndrome, ophthalmoplegia, and polyneuritis cranialis. There is currently a 
limited number of publications that have been able to elaborate the 
neurological impact of COVID-19 on ocular tissues. To the best of our 




COVID-19 has neurotropic effects which can result in decompensation 
for patients with strabismus. Understanding the neurological 
manifestations of the disease may help in the recognition and 
diagnosis while promoting the need for targeted therapeutics. This is 
the first reported case we are aware of with decompensated 
strabismus due to COVID-19.
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A 27-year-old female presents to the emergency room with acute onset 
horizontal binocular diplopia and a history of COVID-19 infection 1-2 
weeks prior. She has a history of longstanding intermittent right esotropia, 
myopia, and well-treated amblyopia in the right eye with excellent best 
corrected visual acuity. She states that before her COVID-19 infection she 
only had double vision after extended reading and typically sees clearly. 
Now she has constant double vision which started acutely earlier that day 
and worsened over the several hours. Her only other symptom at the time 
was increased fatigue. She was afebrile and denies having any respiratory 
or GI symptoms. During examination of eye tracking, there was a left 
esotropia when looking left and a right esotropia when looking right. Labs 
showed a normal WBC count, C-Reactive Protein, and ESR. The CT 
angiogram of the head with and without contrast, chest X-ray, and MRI of 
brain without contrast showed no abnormalities.
▪The present case illustrates an acute strabismus decompensation as a 
neurological manifestation of COVID-19 infection. Based on our scientific 
literature review, this is the first reported case of decompensated 
strabismus as a direct result of COVID-19 infection.
▪Strabismus is an anomaly of ocular alignment found in 2-4% of the 
population and is responsible for complications such as diplopia and 
amblyopia. Many cases are congenital; however, instances of acute 
strabismus may be seen in association with viral infections.
▪There are few studies on the spectrum of neuro-ophthalmologic 
manifestations that occur in association with COVID-19. Consuelo 
Gutiérrez-Ortiz et al. presented 2 cases of COVID-19, one with Miller-fisher 
syndrome and another with polyneuritis cranialis. The author hypothesized 
that these manifestations may be due to an aberrant immune response to 
COVID-19.[7] Marc Dinkin et al. described 2 cases of COVID-19 after 
presenting with diplopia and ophthalmoparesis.[6] It was hypothesized in 
one case to be a direct neurological infection, because there were 
neurologic manifestations within a few days of COVID-19 onset. In both 
cases, it was stated that acute cranial neuropathy should prompt 
consideration for COVID-19.[6][7] Overall, these publications may share 
similarities to our case with respect to the possible pathophysiological 
pathway, though the exact mechanism has yet to be thoroughly explored. 
▪SARS-CoV-2 is an emerging strain of virus causing infections on a 
pandemic scale. Its neurological effects are poorly understood and may 
have a long-term impact that signifies a burden to the patient and the 
health care system. Understanding the neurological manifestations on 
ocular tissues may help in the recognition and diagnosis of the disease 
while promoting the need for targeted therapeutics. Further studies are 
needed to understand the pathogenesis of neurological manifestations 
due to COVID-19.
She was discharged with a Medrol Dosepak for 6th nerve palsy with follow 
up as needed. Around 3 weeks later, she presented to the optometrist 
with horizontal diplopia. She states the diplopia has been stable and 
constant since her visit to the emergency department 3 weeks prior. On 
physical examination, her visual acuity was 20/20 in both eyes with a 
corrective lens. Motility was full to ductions and versions. An alternating 
esotropia greater than 45 prism diopters was found with the cover-
uncover test. Confrontational visual fields were full to count fingers. Pupils 
were equal, round, and reactive to light with no afferent pupillary defect. 
Intraocular eye pressure was measured to be 18 mmHg in both eyes via 
Goldmann tonometry. Slit lamp and dilated fundoscopic exam was 
unremarkable. She was diagnosed with alternating esotropia after 
decompensation of an intermittent esotropia in the right eye. Three weeks 
later during follow up, she reports a gradual and small improvement of the 
diplopia in her near vision. Her distance vision, however, is still perceived 
to be doubled with little to no improvement.
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